Ashesh Thaker, MD
Associate Professor, Radiology

Chief of Neuroradiology, Denver Health
Clinic 303-436-6000
Print Profile
Email Profile
Featured Provider Photo

Gender: Male
Languages: English, Spanish, Gujarati
Department, Section/Division: Radiology

Practice Locations

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000
More providers at this location

Hospital Affiliation
  • Denver Health Medical Center
Center Affiliations

Specialty Information

Specialties
  • Radiology - Diagnostic, Board Certification (2015)
  • Radiology - Neuroradiology, Board Certification (2017)
Conditions & Treatments
  • Radiology
  • CT Scans
  • Magnetic Resonance Imaging (MRI)
  • Neuroradiology
Clinical Interest for Patients
My clinical interests include diagnostic imaging of neurodegenerative disorders, including Alzheimer's disease, and epilepsy. I also have clinical expertise in the diagnosis and treatment of spinal CSF leak.

Education & Training

Medical Schools:
  • MD, University of California, Los Angeles David Geffen School of Medicine (2009)

Undergraduate Schools:
  • BA, University of Colorado - Boulder (CO) (2004)

Internships:
  • Santa Clara Valley Medical Center Program (2010)

Residency Program:
  • University of Pennsylvania Health System Program, Radiology (2014)

Fellowships:
  • University of California (San Francisco) Program, Neuroradiology (2016)

Professional Memberships

  • American College of Radiology, Member
  • American Roentgen Ray Society, Member
  • American Society of Functional Neuroradiology, Member
  • American Society of Neuroradiology, Senior Member
  • Colorado Radiological Society, Treasurer
  • European Society of Radiology, Corresponding Member
  • Radiological Society of North America, Member
  • Western Neuroradiological Society, Member

Teaching

  • Associate Professor (2023)
    School of Medicine, Radiology
  • Assistant Professor (2016)
    School of Medicine, Radiology

Research & Grants

https://www.ncbi.nlm.nih.gov/myncbi/1xopzDv10g3kc/bibliography/public/
Grants
  • Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease (2022)
    National Institute on Aging, NIH, $20370
  • GM-CSF/sargramostim treatment to improve cognition in Down syndrome (2022)
    National Institute on Aging, NIH, $10185
  • Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease (2021)
    National Institute on Aging, NIH, $18673
  • GM-CSF/sargramostim treatment to improve cognition in Down syndrome (2021)
    National Institute on Aging, NIH, $2546